We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Curevac
29 own
10 watching
Current Price
$11.39
$0.14
(1.24%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,131.31M
52-Week High
20.6
52-Week Low
5.63
Average Volume
0.77M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,131.31M52-Week High20.652-Week Low5.63Average Volume0.77MDividend Yield--P/E Ratio--What does the Curevac do?
We are a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. Our vision is to revolutionize medicine and open new avenues for developing therapies by enabling the body to make its own drugs. --- Our principal executive offices are located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany. Our telephone number at this address is +49 7071 98830. Our principal website is www.curevac.com.
Read More
News & Events about Curevac.
Invezz News
10days ago
Shares of CureVac BV (NASDAQ: CVAC) have already almost doubled year-to-date but a UBS analyst says the stock still has a lot more room to the upside. CureVac stock could gain close to 100% On Thursday, Eliana Merle turned bullish on the biopharmaceutical firm and sharply increased her price ...
PR Newswire
20days ago
Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? PR Newswire NEW YORK, Jan. 9, 2023...
Accesswire
20days ago
Dr. Franz-Werner Haas to complete successful tenure as CEO by March 31, 2023Dr. Alexander Zehnder to succeed Dr. Haas as new CEO, joining from Sanofi onApril 1, 2023TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 9, 2023 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical...
Accesswire
23days ago
Promising COVID-19 and flu modified mRNA vaccine candidates identified based on positive preliminary data from ongoing Phase 1 studiesAll candidates use CureVac's advanced second-generation mRNA backbone optimized to achieve improved mRNA translation and strong immune responses at low dosesThe...
Accesswire
2 months ago
Data confirm CV8102's safety and ability to strongly mobilize the immune system against tumorsFinal data of complete Phase 1 dose-escalation and expansion study expected in H1 2023TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 11, 2022 / CureVac N.V. (Nasdaq:CVAC), a global...
Frequently Asked Questions
Frequently Asked Questions
What is Curevac share price today?
Can Indians buy Curevac shares?
How can I buy Curevac shares from India?
Can Fractional shares of Curevac be purchased?
What are the documents required to start investing in Curevac stocks?
What is today’s traded volume of Curevac?
What is today’s market capitalisation of Curevac?
What is the 52-Week High and Low Range of Curevac?
What percentage is Curevac down from its 52-Week High?
What percentage is Curevac up from its 52-Week Low?
Current Price
$11.39
$0.14
(1.24%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.